Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2004
Experimentally exploring the conformational space sampled by domain reorientation in calmodulinIvano Bertini, Cristina Del Bianco, Ioannis Gelis, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 28, 2016
JNK1 ablation in mice confers long-term metabolic protection from diet-induced obesity at the cost of moderate skin oxidative damageBarbara Becattini, Fabio Zani, Ludovic Breasson, et al.Oncotarget|November 17, 2016
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restrictionSilvia Bono, Matteo Lulli, Vito Giuseppe D'Agostino, et al.Journal of Pineal Research|June 28, 2005
Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effectsGrazia Cini, Bruno Neri, Alessandra Pacini, et al.Oncotarget|April 2, 2016
The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression levelNatthakan Thongon, Ilaria Castiglioni, Chiara Zucal, et al.Oxidative Medicine and Cellular Longevity|March 27, 2018
Autophagy Stimulus Promotes Early HuR Protein Activation and p62/SQSTM1 Protein Synthesis in ARPE-19 Cells by Triggering Erk1/2, p38MAPK, and JNK Kinase PathwaysNicoletta Marchesi, Natthakan Thongon, Alessia Pascale, et al.Oncotarget|April 25, 2015
Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibitionIrene Caffa, Vito D'Agostino, Patrizia Damonte, et al.Autophagy|December 19, 2024
Autophagy induction by piplartine ameliorates axonal degeneration caused by mutant HSPB1 and HSPB8 in Charcot-Marie-Tooth type 2 neuropathiesAngela Sisto, Tamira van Wermeskerken, Michael Pancher, et al.Human Molecular Genetics|January 23, 2010
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanomaAlessandra Bisio, Sabina Nasti, Jennifer J Jordan, et al.Oncotarget|October 27, 2015
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 bindingAlessandra Bisio, Elisa Latorre, Virginia Andreotti, et al.Pageof 7